Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer

Pancreas

Volumn 35, Issue 2, 2007, Pages 135-141

  Crous Bou, Marta ^a,b   Porta, Miquel ^a,b   López, Tomàs ^a   Jariod, Manuel ^a,c   Malats, Núria ^a   Alguacil, Juan ^a,d   Morales, Eva ^a   Fernandez, Esteve ^e,f   Corominas, Josep M ^b,g   Carrato, Alfredo ^h   Guarner, Luisa ^b,i   Real, Francisco X ^a,f  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^d UNIVERSITY OF HUELVA   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g HOSPITAL DEL MAR   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Etiology; K ras oncogene; Pancreatic neoplasms; ras genes; Smoking; Tobacco

Indexed keywords

K RAS PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CIGARETTE SMOKING; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; ONCOGENE RAS; ONSET AGE; PANCREAS CANCER; PANCREAS DUCT; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

CASE-CONTROL STUDIES; CODON; GENES, RAS; HUMANS; INTERVIEWS; MUTATION; PANCREATIC NEOPLASMS; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 34447526285     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/mpa.0b013e31805d8fa4     Document Type: Article

References (53)

1. Porta M, Malats N, Jariod M, et al. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. Lancet. 1999;354:2125-2129.
2. Weiderpass E, Partanen T, Kaaks R, et al. Pancreatic cancer: occurrence, trends, and environmental etiology. A review. Scand J Work Environ Health. 1999;24:165-174.
3. Ekbom A, Hunter D. Pancreatic cancer. In: Adami HO, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology. New York: Oxford University Press; 2002:233-247.
4. Li D, Jiao L, Porta M. Epidemiology. In: von Hoff DD, Evans DB, Hruban RH, eds. Pancreatic Cancer. Boston: Jones and Bartlett; 2005:103-117.
5. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3:733-744.
6. Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer. 2002;2:455-463.
7. Fernandez E, La vecchia C, Decarli A. Attributable risks for pancreatic cancer in northern Italy. Cancer Epidemiol Biomarkers Prev. 1996;5:23-27.
8. Ferraroni M, Negri E, La Vecchia C, et al. Socioeconomic indicators, tobacco and alcohol in the aetiology of digestive tract neoplasms. Int J Epidemiol. 1989;18:556-562.
9. Bonelli L, Aste H, Bovo P, et al. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. Pancreas. 2003;27:143-149.
10. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003;3:459-465.
11. Hezel AF, Kimmelman AC, Stanger BZ, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006;20:1218-1249.
12. Shields JM, Pruitt K, McFall A, et al. Understanding ras: "it ain't over 'til it's over". Trends Cell Biol. 2000;10:147-154.
13. Porta M, Ayude D, Alguacil J, et al. Exploring environmental causes of altered ras effects: fragmentation plus integration? Mol Carcinog. 2003;36:45-52.
14. Porta M, Malats N, Guarner L, et al. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health. 1999;53:702-709.
15. Alguacil J, Porta M, Malats N, et al. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer. Carcinogenesis. 2002;23:101-106.
16. Alguacil J, Porta M, Kauppinen T, et al. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer. Int J Cancer. 2003;107:635-641.
17. Real FX. A "catastrophic hypothesis" for pancreas cancer progression. Gastroenterology. 2003;124:1958-1964.
18. Wark PA, Van der Kuil W, Ploemacher J, et al. Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas. Int J Cancer. 2006;119:398-405.
19. Nagata Y, Abe M, Motoshima K, et al. Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese. Jpn J Cancer Res. 1990;81:135-140.
20. Hruban RH, van Mansfeld AD, Offerhaus GJ, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol. 1993;143:545-554.
21. Malats N, Porta M, Corominas JM, et al. Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. Int J Cancer. 1997;70:661-667.
22. Berger DH, Chang H, Wood M, et al. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status. Cancer. 1999;85:326-332.
23. Slebos RJ, Hoppin JA, Tolbert PE, et al. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiol Biomarkers Prev. 2000;9:1223-1232.
24. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer. 2001;31:139-148.
25. Thun MJ, Lally CA, Flannery JT, et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997;89:1580-1586.
26. Yun YH, Lim MK, Jung KW, et al. Relative and absolute risks of cigarette smoking on major histologic types of lung cancer in Korean men. Cancer Epidemiol Biomarkers Prev. 2005;14:2125-2130.
27. Sobue T, Yamamoto S, Hara M, et al. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer. 2002;99:245-251.
28. Gealy R, Zhang L, Siegfried JM, et al. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomarkers Prev. 1999;8:297-302.
29. Slebos RJ, Hruban RH, Dalesio O, et al. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst. 1991;83:1024-1027.
30. Boffetta P, Trichopoulos D. Cancer of the lung, larynx, and pleura. In: Adami HO, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology. New York: Oxford University Press; 2002:248-280.
31. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002;252:206-224.
32. Porta M, Fabregat X, Malats N, et al. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol. 2005;7:189-197.
33. Soler M, Malats N, Porta M, et al. Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. Dig Dis Sci. 1999;44:2469-2477.
34. Porta M, Costafreda S, Malats N, et al. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. Eur J Epidemiol. 2000;16:533-541.
35. Rosenbaum PR. The case-only odds ratio as a causal parameter. Biometrics. 2004;60:233-240.
36. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4th ed. Oxford: Blackwell, 2002.
37. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Belmont, CA: Lifetime Learning Publications; 1982:320-376, 343, 419-456.
38. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol I: The Analysis of Case-Control Studies. Lyon: IARC Scientific Publications; 1980:149-154.
39. Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156:2255-2260.
40. Silverman DT, Dunn JA, Hoover RN, et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1994;86:1510-1516.
41. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, et al. Life-time history of smoking and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer. 1991;49:816-822.
42. Boyle P, Maisonneuve P, Bueno de Mesquita B, et al. Cigarette smoking and pancreas cancer: a case control study of the SEARCH programme of the IARC. Int J Cancer. 1996;67:63-71.
43. Howe GR, Jain M, Burch JD, et al. Cigarette smoking and cancer of the pancreas: evidence from a population-based case-control study in Toronto, Canada. Int J Cancer. 1991;47:323-328.
44. Porta M, Malats N, Corominas JM, et al. Generalizing molecular results arising from incomplete biological samples: expected bias and unexpected findings. Ann Epidemiol. 2002;12:7-14.
45. Askari MD, Tsao M, Cekanova M, et al. Ethanol and the tobacco-specific carcinogen, NNK, contribute to signaling in immortalized human pancreatic duct epithelial cells. Pancreas. 2006;33:53-62.
46. Baskaran K, Laconi S, Reddy MK. Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butatone (NNK), in vitro. Carcinogenesis. 1994;15:2461-2466.
47. Sills RC, Boorman GA, Neal JE, et al. Mutations in ras genes in experimental tumours of rodents. IARC Sci Publ. 1999;146:55-86.
48. Ross JA, Nesnow S. Polycyclic aromatic hydrocarbons: correlations between DNA adducts and ras oncogene mutations. Mutat Res. 1999;424:155-166.
49. Tretyakova N, Matter B, Jones R, et al. Formation of benzo[a]pyrene diol epoxide-DNA adducts at specific guanines within K-ras and p53 gene sequences: stable isotope-labeling mass spectrometry approach. Biochemistry. 2002;41:9535-9544.
50. De Stefani E, Boffetta P, Ronco AL, et al. Squamous and small cell carcinomas of the lung: similarities and differences concerning the role of tobacco smoking. Lung Cancer. 2005;47:1-8.
51. Berrozpe G, Schaeffer J, Peinado MA, et al. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer. 1994;58:185-191.
52. Deramaudt T, Rustgi AK. Mutant KRAS in the initiation of pancreatic cancer. Biochim Biophys Acta. 2005;1756:97-101.
53. Wallerand H, Bakkar AA, de Medina SG, et al. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Carcinogenesis. 2005;26:177-184.